| Dixie L Harris, MD | |
|
170 N 1100 E, American Fork, UT 84003-2096 | |
| (801) 855-4222 | |
| Not Available |
| Full Name | Dixie L Harris |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 35 Years |
| Location | 170 N 1100 E, American Fork, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740296730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 59890071205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Utah Valley Hospital | Provo, UT | Hospital |
| American Fork Hospital | American fork, UT | Hospital |
| Alta View Hospital | Sandy, UT | Hospital |
| Intermountain Medical Center | Murray, UT | Hospital |
| Riverton Hospital | Riverton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
The Los Angeles Times: "National healthcare legislation in Congress could slow the growth of medical costs, allowing employers to create 250,000 to 400,000 new jobs a year over the next decade, economists from Harvard University and USC are predicting.
Use of implantable cardioverter-defibrillators (ICDs) programmed with long-detection intervals for ventricular arrhythmias was associated with an increase in the time to first hospitalization and reductions in hospitalization rate, length of stay and costs, compared with standard interval programming, according to a study in the August 6 issue of JAMA.
Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
The Los Angeles Times: "National healthcare legislation in Congress could slow the growth of medical costs, allowing employers to create 250,000 to 400,000 new jobs a year over the next decade, economists from Harvard University and USC are predicting.
Use of implantable cardioverter-defibrillators (ICDs) programmed with long-detection intervals for ventricular arrhythmias was associated with an increase in the time to first hospitalization and reductions in hospitalization rate, length of stay and costs, compared with standard interval programming, according to a study in the August 6 issue of JAMA.
Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dixie L Harris, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: (801) 855-4222 | Dixie L Harris, MD 170 N 1100 E, American Fork, UT 84003-2096 Ph: (801) 855-4222 |
News Archive
The Los Angeles Times: "National healthcare legislation in Congress could slow the growth of medical costs, allowing employers to create 250,000 to 400,000 new jobs a year over the next decade, economists from Harvard University and USC are predicting.
Use of implantable cardioverter-defibrillators (ICDs) programmed with long-detection intervals for ventricular arrhythmias was associated with an increase in the time to first hospitalization and reductions in hospitalization rate, length of stay and costs, compared with standard interval programming, according to a study in the August 6 issue of JAMA.
Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
A new study suggests that there is a significant correlation between excessive daytime sleepiness and vitamin D, and race plays an important factor.
› Verified 6 days ago
Wynn H Hemmert, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 36 N 1100 E, Suite A, American Fork, UT 84003 Phone: 801-772-0775 Fax: 801-772-1941 | |
Ms. Yun Ling, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S, Suite 241, American Fork, UT 84003 Phone: 801-492-5999 Fax: 801-418-0897 | |
Dr. David Allen Bradshaw, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 98 N 1100 E Ste 302, American Fork, UT 84003 Phone: 801-492-2270 | |
Dr. Michael Bryant Jolley, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-357-8310 | |
Nathan Robert Brewster, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 98 N 1100 E Ste 302, American Fork, UT 84003 Phone: 801-492-2270 | |
Terry C Hammond, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S Ste 161, American Fork, UT 84003 Phone: 801-377-4623 Fax: 801-377-6832 | |
Von F Welch, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1159 E 200 N, Suite 150, American Fork, UT 84003 Phone: 801-855-2900 |